Repligen Corp.

Repligen is a provider of bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The company's bioprocessing business is comprised of: Chromatography, which includes products used in the downstream purification and quality control of biological drugs; Filtration, which include KrosFlo? line of hollow-fiber cartridges and tangential flow filters systems, the Spectra/Por? portfolio of laboratory and process dialysis products and Pro-Connex? single-use hollow-fiber Module-Bag-Tubing sets; and OEM Products (Proteins), which are a component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products.
  • TickerRGEN
  • ISINUS7599161095
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

Repligen Corp: 1 director sold

A director at Repligen Corp sold 4,455 shares at 92.807USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

REPLIGEN CORP. increases its risk exposure and slightly lowers to Neutral

REPLIGEN CORP. (US), a company active in the Medical Equipment industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 2 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date February 21, 2020, the closing price was USD 98.11 and its expected value was estimated at USD 99.30.

Repligen Corp: 1 director sold

A director at Repligen Corp sold 4,455 shares at 92.807USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

REPLIGEN CORP. increases its risk exposure and slightly lowers to Neutral

REPLIGEN CORP. (US), a company active in the Medical Equipment industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 2 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date February 21, 2020, the closing price was USD 98.11 and its expected value was estimated at USD 99.30.

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

ValuEngine Rating and Forecast Report for RGEN

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of Consumer Cyclical names continue to reflect leadership. (ex. SBUX, RRGB, MCD, PZZA, and ROST.) • The Financial Sector has a number of attractive names developing major bases and staging RS reversals. (ex. SIVB, STT, AXP, SPGI, CME, GS, and JEF) • The Technology Sector has a number of technically attractive constituents. (ex. AMD, OLED, MPWR, CRUS, BR, FIS, VRSN, SAIC, LDOS, AAOI, BELFB, FARO, STX, and AAPL) .

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

MSCI ACWI, STOXX 600 Breaking Out The market continues to feed off of optimism surrounding the US-China “phase one” trade deal. Boris Johnson's UK election victory has added an additional tailwind, particularly in the UK and Europe, where the UK's FTSE 250 and the STOXX Europe 600 indexes are breaking out to all-time highs. At some point the euphoria is likely to wear off, but with continued global bullish developments, it remains our belief that pullbacks should be bought and that global equities are in the early stages of a broad-based advance. • Sector Relative Strength Rankings (RSR) & W...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Many Consumer Discretionary names are staging reversals or developing bullish bases. (ex. CPRI, CRI, OXM, PENN, LOCO, PZZA, DPZ, WW, CHS, ZUMZ, and GES) • The Healthcare Sector has a significant number of names reversing downtrend, breaking out of bases, and in uptrends (ex. CAH, TCMD, THC, SEM, MGLN, RGEN, REGN, MEDP, PRAH, and BMY) • Semis and Semi suppliers continue to develop positively. (ex. UCTT, ICHR, FORM, AEIS, and BRKS)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

• A number of Healthcare names are pulling back to logical support areas. (ex. EW, EGRX, ARWR, RGEN, LCI, CTLT, and PBH) • The Technology Sector continues to have a number of technically attractive names that are pulling back to support levels. (ex. FORM, MKSI, NVDA, MU, SYNA, ANSS, COHR, and WDC) • Defensive Sectors such REITs and Consumer Staples remain leadership. (ex. LW, PEP, UHT, NSA, COR, and LSI)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Homebuilders continue to be leadership. (ex. MTH, PHM, and MHO) • A number of Transportation Sector names are staging price and RS reversals, or remain leadership. (ex. XPO, JBLU, UAL, SKYW, AAL, DAL, UNP, JBHT, KNX, ODFL, LSTR, and SAIA) • Many Materials Sector names appear to be staging price and RS reversals. (ex. DOW, VVV, LYB, MLM, VMC, USCR, EMN, and CMC. )

ResearchPool Subscriptions

Get the most out of your insights

Get in touch